Do J&J and AstraZeneca Vaccines Cause Blood Clots, and What Are the Symptoms?
U.S. health regulators said vaccination with Johnson & Johnson’s Covid-19 shots can resume
Use of Johnson & Johnson’s JNJ -0.57% vaccines could resume as soon as this weekend after U.S. health regulators lifted the pause on the shots Friday evening. J&J and regulators plan to add language to the vaccine’s label warning of a risk of blood clots.
The decision, announced by the Food and Drug Administration and the Centers for Disease Control and Prevention, came after a federal vaccine advisory panel voted earlier that day to resume the shots. The vaccine’s benefits outweigh its risks for people 18 years of age and older, the FDA said.